The effect of alpha-tocopherol on monocyte proatherogenic activity

Area of Science:

• Cardiovascular Science
• Immunology
• Nutritional Science

Background:

• Atherosclerosis is a primary cause of death in Western countries.
• Monocytes play a critical role throughout all stages of atherosclerotic lesion development.
• alpha-Tocopherol (AT) is a potent lipid-soluble antioxidant and the primary form of vitamin E.

Purpose of the Study:

• To investigate the effects of alpha-tocopherol (AT) supplementation on monocyte function in relation to atherosclerosis.
• To elucidate the mechanisms by which AT influences monocyte-mediated inflammatory and adhesion processes.

Main Methods:

• Monocyte function was assessed following AT supplementation (1200 IU/d).
• Evaluated the release of reactive oxygen species, lipid oxidation, and cytokines (IL-1β, TNF-α).
• Examined monocyte adhesion to endothelium and the expression of adhesion molecules (CD11b, VLA-4), and NF-κB activity.

Main Results:

• AT supplementation decreased reactive oxygen species and lipid oxidation in monocytes.
• Reduced the release of pro-inflammatory cytokines, including IL-1β and TNF-α.
• Inhibited monocyte adhesion to endothelium by downregulating CD11b, VLA-4, and NF-κB activation.

Conclusions:

• AT exhibits anti-inflammatory and antiatherogenic properties by modulating monocyte function.
• AT supplementation reduces oxidative stress, cytokine release, and monocyte adhesion, crucial factors in atherogenesis.
• These findings highlight the therapeutic potential of AT in preventing and managing atherosclerosis.